NanoLogix, Inc. (Pink Sheets: NNLX) is pleased to announce the creation of its Science Advisory Board to help evaluate and target research and development efforts for products. The new advisory board provides the company with a vastly expanded scope of expertise in both medicine and biomedical research.
Dr. Robert Ollar, NanoLogix cofounder and author of numerous NanoLogix patents, has resigned from the NanoLogix Board of Directors to assume the position of Chairman of the Science Advisory Board.
NanoLogix Science Advisory Board Members
- Dr. Robert A. Ollar, M. Sc., Ph.D.
- Dr. Brian Caplin, Ph.D.
- Dr. T. Dorai, M.Sc., Ph.D.
- Dr. Sushil Duddempudi, MD
- Dr. Deepak Kumar Mendiratta, MD, Ph.D.
- Dr. Mrs. P. Narang, MD
- Dr. Ravinder Narang, MD
- Cliff Watts, MD
NanoLogix technology is used to design and market diagnostic test kits for use in early detection of bacteria and other microorganisms present in infectious and noninfectious human diseases, the environment, industrial and manufacturing settings, veterinary medicine, and research and testing laboratories.